|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.26 CAD | -0.77% |
|
+1.38% | -3.48% |
| 11-28 | Extendicare to Acquire Nine Long-Term Care Homes from Revera for $60.3 Million | MT |
| 11-28 | Extendicare Price Target Raised to $11 at RBC | MT |
| Capitalization | 856M 598M 575M 543M 486M 51.56B 955M 6.6B 2.44B 21.27B 2.24B 2.2B 93.1B | P/E ratio 2024 * |
-
| P/E ratio 2025 * | - |
|---|---|---|---|---|---|
| Enterprise value | 856M 598M 575M 543M 486M 51.56B 955M 6.6B 2.44B 21.27B 2.24B 2.2B 93.1B | EV / Sales 2024 * |
0.59x | EV / Sales 2025 * | 0.58x |
| Free-Float |
86.08% | Yield 2024 * |
4.68% | Yield 2025 * | 7.93% |
More valuation ratios
* Estimated data
More news
Last Transcript: Extendicare Inc.
More press releases
| 1 day | -0.77% | ||
| 1 week | +1.38% | ||
| Current month | -3.48% | ||
| 1 month | -0.48% | ||
| 3 months | +10.20% | ||
| 6 months | +39.02% | ||
| Current year | -3.48% |
1 week
10.17
10.48
1 month
10.0210.74
Current year
10.0210.63
1 year
6.6310.89
3 years
5.7510.89
5 years
4.9010.89
10 years
4.9010.89
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 2018-10-21 | |
David Bacon
DFI | Director of Finance/CFO | - | 2019-03-31 |
Joe Belinsky
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 1995-02-22 | |
Alvin Libin
BRD | Director/Board Member | - | 1984-01-19 |
Sandra Hanington
BRD | Director/Board Member | 63 | 2014-08-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.25% | 0 M€ | -.--% | ||
| 0.04% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.77% | +1.38% | +43.30% | +41.71% | 598M | ||
| +0.33% | +0.74% | +7.88% | +28.95% | 78.64B | ||
| +1.27% | +2.14% | -28.13% | -48.61% | 66.22B | ||
| -0.90% | -3.95% | +1.13% | +73.73% | 26.97B | ||
| +0.22% | +5.33% | +38.43% | -1.60% | 21.31B | ||
| -6.02% | -6.46% | +137.67% | +151.09% | 20.91B | ||
| -0.09% | +1.91% | +5.49% | -11.93% | 19.95B | ||
| -0.30% | -1.83% | +14.05% | +10.23% | 16.88B | ||
| +0.84% | +5.84% | +58.69% | +51.97% | 13.63B | ||
| -0.89% | +2.46% | +24.93% | -25.44% | 13.58B | ||
| Average | -0.61% | +2.00% | +30.34% | +27.01% | 27.87B | |
| Weighted average by Cap. | -0.15% | +3.15% | +14.34% | +16.12% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 1.45B 1.01B 972M 918M 822M 87.15B 1.61B 11.15B 4.13B 35.95B 3.79B 3.71B 157B | 1.47B 1.02B 984M 929M 832M 88.24B 1.63B 11.29B 4.18B 36.4B 3.84B 3.76B 159B |
| Net income | - | - |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
23,500
Calendar
2025-02-26
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-01-20 | 10.26 $ | -0.77% | 46,651 |
| 25-01-17 | 10.34 $ | +1.17% | 90,211 |
| 25-01-16 | 10.22 $ | -1.35% | 77,036 |
| 25-01-15 | 10.36 $ | +0.48% | 107,940 |
| 25-01-14 | 10.31 $ | +1.88% | 164,464 |
Delayed Quote Toronto S.E., January 20, 2025 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
10.26CAD
Average target price
11.00CAD
Spread / Average Target
+7.21%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EXE Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition